Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Browsing Tag

Pfizer Inc

13 posts
RRoche
Roche Obesity Shot Led to 18% Weight Loss in Study
Read More

Roche Obesity Shot Led to 18% Weight Loss in Study

  • 2026-04-27
Roche Holding AG said patients on its experimental shot lost 18% more weight than those who got placebo…
UUBS
UBS Adjusts Pharma Outlook, Increases Pfizer (PFE) Price Target
Read More

UBS Adjusts Pharma Outlook, Increases Pfizer (PFE) Price Target

  • 2026-04-16
Pfizer Inc. (NYSE:PFE) is included among the 14 Value Stocks with Highest Dividends. UBS Adjusts Pharma Outlook, Increases…
NNovartis
Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline
Read More

Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline

  • 2026-04-02
Company Logo The market offers key opportunities through the growth of personalized therapies, adoption of monoclonal antibodies, digital…
NNovartis
Global Industry Assessment Featuring Pfizer, Merck & Co., Bristol-Myers Squibb, AstraZeneca, Novartis and More
Read More

Global Industry Assessment Featuring Pfizer, Merck & Co., Bristol-Myers Squibb, AstraZeneca, Novartis and More

  • 2026-04-01
Company Logo Advanced Renal Cell Carcinoma Treatment Market Advanced Renal Cell Carcinoma Treatment Market · GlobeNewswire Inc. Dublin,…
NNovartis
Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline
Read More

Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline

  • 2026-03-30
Company Logo The market offers key opportunities through the growth of personalized therapies, adoption of monoclonal antibodies, digital…
RRoche
Roche Breast-Cancer Drug Combination Misses Target in Study
Read More

Roche Breast-Cancer Drug Combination Misses Target in Study

  • 2026-03-13
Roche Holding AG’s experimental breast-cancer pill failed to meet the main goal of a study, a blow to…
RRoche
Roche shares drop after oral breast cancer drug trial
Read More

Roche shares drop after oral breast cancer drug trial

  • 2026-03-09
Sopa Images | Lightrocket | Getty Images Roche’s shares dropped more than 5% on Monday as the ​Swiss…
RRoche
Novartis, Roche Near US Drug Price Deal as White House Prepares Announcement
Read More

Novartis, Roche Near US Drug Price Deal as White House Prepares Announcement

  • 2026-02-27
The White House is set to announce drug pricing deals with pharmaceutical heavyweights Novartis AG and Roche Holding…
RRoche
Roche agrees $7.1 billion deal to buy Telavant Holdings
Read More

Roche joins race for obesity drugs with $2.7 billion Carmot deal

  • 2026-02-20
A photo showing the logo of Swiss pharmaceutical giant Roche in Basel. SEBASTIEN BOZON | AFP | Getty…
RRoche
Bispecific Antibodies Market - Global Forecast 2025-2032, Profiles of Key Players
Read More

Bispecific Antibodies Market – Global Forecast 2025-2032, Profiles of Key Players

  • 2026-02-15
Company Logo The bispecific antibodies market presents key opportunities in oncology, autoimmune, and infectious diseases, driven by rapid…
RRoche
Novartis, Roche could be most at risk
Read More

Novartis, Roche could be most at risk

  • 2026-02-14
Medications are stored on shelves at a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer…
RRoche
Roche, Zealand Pharma's $5.3 billion obesity drug bet
Read More

Roche, Zealand Pharma’s $5.3 billion obesity drug bet

  • 2026-02-14
The Roche Holding AG headquarters on April 11, 2025, in Basel, Switzerland. Sedat Suna | Getty Images News…
Switzerland
www.europesays.com